CTXRNasdaqPharmaceutical PreparationsFiscal year ends September 30
Citius Pharmaceuticals, Inc.
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.43−0.03 (-7.00%)
Close on Oct 19, 2026
- Market cap
- $11.20M
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Dividend declared per share by fiscal year, adjusted for stock splits
Per share, FY2025
–
Consecutive increases
0 years
Not raised last year
Five-year growth
–
Per year, per share
Payout ratio, FY2025
–
Dividends paid ÷ net income
Dividend history
By fiscal year
| Fiscal year | Per share | Change | Cash paid | Payout ratio |
|---|---|---|---|---|
| FY2025 | – | – | – | – |
| FY2024 | – | – | – | – |
| FY2023 | – | – | – | – |
| FY2022 | – | – | – | – |
| FY2021 | – | – | – | – |
| FY2020 | – | – | – | – |
| FY2019 | – | – | – | – |
| FY2018 | – | – | – | – |
| FY2017 | – | – | – | – |
| FY2016 | $225.00 | – | – | – |
Ex-dividend and payment dates for each distribution will appear once a dividend calendar source is connected.